Twist Biosciences: AI-Driven Rally Or Short Squeeze? I'm Neutral (For Now)
Twist Bioscience Stock Resilient Despite Scorpion Capital Short Report
Watching Twist Bioscience; Scorpion Capital Issues Report On Co, States They Hold A Short Position
Twist Bioscience Stock Hits 52-Week High - Here's Why
Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript
Twist Bioscience (TWST) Is Up 26.3% After Capital Raise And Guidance Hike Amid Legal Settlement Talks - Has The Bull Case Changed?
Twist Bioscience Corporation 2026 Q3 - Results - Earnings Call Presentation
Revenue Growth Reinforces Twist Bioscience Corp.’s (TWST) Technology Leadership
Piper Sandler Maintains Overweight on Twist Bioscience, Raises Price Target to $115
Twist Biosciences: Accelerating Growth, Diminishing Margin Of Safety
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
Twist Bioscience Corporation Q3 2026 Earnings Call Summary
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $115
Twist Bioscience Corp (TWST) (Q3 2026) Earnings Call Highlights: Record Revenue and AI-Driven ...
Twist Bioscience Q3 Earnings Call Highlights
Twist Bioscience Corporation (TWST) Q3 2026 Earnings Call Transcript
Twist Bioscience Shares Decline Following Quarterly Earnings Miss
Twist Bioscience Sees AI Drug Discovery Pipeline Expand
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.